Good afternoon :)
$
₹
Medtronic PLC

Medtronic PLC

MDT

NYSE
Asset Logo

Medtronic PLC

MDT

NYSE
$93.810.01% (+0.01)
$
₹
$93.810.01% (+0.01)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
Loading...
1D
1W
1M
1Y
5Y
Max

Healthcare

Medical Devices

Large Cap

With a market cap of $120.0B the stock is ranked 142

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

23.10
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

2.31
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$4.06
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

1.63
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

13.93%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

3.13%

Analyst Ratings & Forecast
Analyst Ratings & Forecast

Based on 32 analysts' reports

Buy
17 analysts
Hold
13 analysts
Sell
2 analysts

Analysts expect a +11.74% price upside over the next year

Current Price$93.81
Target Price$104.76

Company Profile

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, left atrial appendage exclusion systems, extracorporeal membrane oxygenation (ECMO) systems and percutaneous coronary intervention products, percutaneous angioplasty balloons, and endovenous products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. This segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products, as well as insulin pumps and consumables, continuous glucose monitoring sys
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, left atrial appendage exclusion systems, extracorporeal membrane oxygenation (ECMO) systems and percutaneous coronary intervention products, percutaneous angioplasty balloons, and endovenous products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. This segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products, as well as insulin pumps and consumables, continuous glucose monitoring sys

Peers

Peers

Abbott Laboratories
ABT
Abbott Laboratories
P/E Ratio
33.36
33.36
1Y Return
21.15%
21.15%
Buy Reco %
74.07
74.07
Danaher Corporation
DHR
Danaher Corporation
P/E Ratio
36.29
36.29
1Y Return
11.23%
11.23%
Buy Reco %
88.00
88.00
Intuitive Surgical Inc
ISRG
Intuitive Surgical Inc
P/E Ratio
43.39
43.39
1Y Return
13.09%
13.09%
Buy Reco %
66.66
66.66
Stryker Corporation
SYK
Stryker Corporation
P/E Ratio
29.23
29.23
1Y Return
25.18%
25.18%
Buy Reco %
68.75
68.75
Boston Scientific Corp
BSX
Boston Scientific Corp
P/E Ratio
18.23
18.23
1Y Return
56.07%
56.07%
Buy Reco %
91.17
91.17

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareMedical Devices

Valuation

Returns

Forecast

StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Medtronic PLC 23.102.311.63
Abbott Laboratories33.363.451.87
Danaher Corporation36.292.671.19

Price Comparison

Price Comparison

1 Month

1 Year

5 Years

Loading...

Financials

Financials

Income

Balance Sheet

Cash Flow

8.9
1.3
9
1.1
9.8
1.2
9.7
1.4
Q4 2025
Q1 2026
Q2 2026
Q3 2026
Revenue
Net Income
Financial YearQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026
Total Revenue8.587.918.408.298.928.578.969.019.809.75
Net Income0.651.041.271.291.051.041.371.141.241.47
Net Profit Margin7.61%13.16%15.11%15.60%11.84%12.12%15.33%12.67%12.67%15.06%
See CostsAll values in $ Billion

Frequently asked questions

Frequently asked questions

  1. Medtronic PLC (MDT) share price today is $93.81 as of September 16, 2026 at 1:30 AM IST. The stock touched a day high of $94.68 and a day low of $92.77.

  2. Medtronic PLC stock trades on NYSE under the ticker symbol MDT.

  3. Medtronic PLC's market capitalization is $119.98B as of September 16, 2026 at 1:30 AM IST.

  4. Medtronic PLC's price-to-earnings (P/E) ratio is 23.10 as of September 16, 2026.

  5. Medtronic PLC's price-to-book (P/B) ratio is 2.31 as of September 16, 2026.

  6. Yes, Medtronic PLC pays a dividend, with a current dividend yield of 3.13%.

  7. Yes, You can buy Medtronic PLC shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  8. Indian investors can buy Medtronic PLC shares in three steps: 1. Search Medtronic PLC on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  9. Since Medtronic PLC trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  10. Indian investors can start investing in Medtronic PLC (MDT) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.1065 shares at the current price of $93.81.

Loading...